Latest in Biden proposes huge expansion of US weight loss drug coverage
Sort by
3,406 items
-
Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales
US group revises down upper end of full-year revenue estimatesBusiness - Financial Times - October 30 -
Hoping for a weight-loss pill? It could get closer to reality next week.
Viking Therapeutics Inc.’s stock rose 2% Friday as excitement continued to build about data on its oral weight-loss drug the company will present at the upcoming Obesity Week event.Business - MarketWatch - November 2 -
The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.Top stories - CBS News - November 4 -
Mother-of-two dies during Turkey weight-loss op
Janet Savage paid £2,750 for the procedure but stopped breathing during surgery.Top stories - BBC News - November 11 -
Not just for weight loss: Wegovy may help curb alcohol addiction
The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.Top stories - NBC News - November 13 -
Viking Therapeutics is more than just a weight-loss stock, and that’s drawing cheers
The biotech’s liver-disease treatment is also viewed as best-in-class, earning it a full slate of buy ratings from analysts.Business - MarketWatch - 5 days ago -
Google told to sell browser Chrome to end dominance of online search
The tech giant is resisting fiercely, calling the proposal "wildly overbroad" and claiming it will hurt consumers.Top stories - BBC News - 6 days ago -
DoorDash keeps investing in expansion, as more consumers use platform in third quarter
DoorDash Inc. on Wednesday reported third-quarter results and a fourth-quarter demand outlook that topped expectations, as the company continues to invest in expansion and improving service.Business - MarketWatch - October 31 -
-
As many as 1 in 5 people won't lose weight with GLP-1 drugs, experts say
About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to several obesity experts.Top stories - CBS News - Yesterday -
Biden proposes to restrict pollution from new gas plants
The Biden administration has proposed a rule that it says will reduce pollution stemming from new gas-fired power plants and other industrial facilities. The proposal would require these plants to ...Politics - The Hill - 4 days ago -
Pelicot trial: young vineyard worker proposed drugging and raping his own mother
Video showed Charly A, one of 51 men accused of raping Gisèle Pelicot, discussing plan with Dominique Pelicot. A young vineyard worker accused of raping Gisèle Pelicot on six occasions over four ...World - The Guardian - November 15 -
GOP senator: Using military for deportations would be 'huge mistake'
Kentucky Sen. Rand Paul (R) denounced the possibility of using the U.S. military for mass deportations, which President-elect Trump has said he'd be open to in recent days. "I will not support an ...Politics - The Hill - 6 days ago -
Angela Merkel expresses ‘huge concern’ at Elon Musk’s US government role
Former German chancellor says politics should govern the social balance between powerful and ordinary citizens. Angela Merkel, who in her new memoir raises fears for the western democratic order ...World - The Guardian - 4 days ago -
How Harris’s Loss Could Haunt Biden’s Legacy
In the wake of Donald J. Trump’s resounding victory, many Democrats are casting President Biden as a one-term president who set his party on a path to failure in 2024.Top stories - The New York Times - November 6 -
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill.Business - MarketWatch - November 5 -
Biden wants drugs like Wegovy, Ozempic covered by Medicare, Medicaid
Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and Medicaid under a rule the Biden administration has proposed.Top stories - CBS News - Yesterday -
Biden wants drugs like Wegovy, Ozempic covered by Medicare, Medicaid
Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and Medicaid under a rule the Biden administration has proposed.Politics - CBS News - 18 hours ago -
Closure of UK inheritance tax ‘loophole’ to penalise estates of wealthy pensioners
Experts say big tax bills could result from Rachel Reeves’ move in the BudgetBusiness - Financial Times - October 30 -
FDA proposes ending use of decongestant found in many cold, allergy medicines
The FDA said the proposed order is not final yet, which means companies can still market over-the-counter drugs containing oral phenylephrine for now.Business - CNBC - November 7 -
FDA proposes ending use of decongestant found in many cold, allergy medicines
The FDA has proposed ending the use of an ingredient in many over-the-counter cold and allergy medications because it doesn’t actually relieve nasal congestion.Top stories - NBC News - November 7 -
Lebanon is studying US-drafted ceasefire proposal, official says
Resolution would move Iran-backed Hizbollah troops north of the Litani river and create multinational task forceWorld - Financial Times - November 16 -
US moves to protect giraffes, proposing crack down on body part imports
The Biden administration has proposed new protections for giraffes, saying it would crack down on imports containing giraffe body parts. If finalized, a new proposal would require permits to import ...Politics - The Hill - 6 days ago
